Pictet Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.3M Sell
450,764
-32,635
-7% -$1.66M 0.02% 481
2025
Q4
$24.8M Sell
483,399
-25,526
-5% -$1.24M 0.02% 478
2025
Q3
$24.2M Sell
508,925
-45,557
-8% -$1.83M 0.02% 476
2025
Q2
$17.3M Buy
554,482
+10,569
+2% +$339K 0.02% 544
2025
Q1
$17.6M Buy
543,913
+17,661
+3% +$626K 0.02% 528
2024
Q4
$19M Sell
526,252
-34,343
-6% -$1.21M 0.02% 515
2024
Q3
$17.2M Buy
560,595
+14,696
+3% +$459K 0.02% 531
2024
Q2
$14.6M Sell
545,899
-444,137
-45% -$12.9M 0.02% 549
2024
Q1
$33.6M Sell
990,036
-56,046
-5% -$1.67M 0.04% 380
2023
Q4
$30.3M Buy
1,046,082
+125,530
+14% +$3.33M 0.03% 388
2023
Q3
$25.4M Buy
+920,552
New +$28M 0.03% 404

Other funds holding SUPN